Related Experiment Video
Updated: Mar 1, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Expert Consensus Survey on Medication Adherence in Psychiatric Patients and Use of a Digital Medicine System
Ainslie Hatch1,2,3, John P Docherty2,3, Daniel Carpenter2,3
1ODH, Inc, 508 Carnegie Center Blvd, Ste 300, Princeton, NJ 08540. ainslie.hatch@ODHsolutions.com.
Background:
There is an unmet need to objectively assess adherence problems that are a common cause of unexplained or unexpected suboptimal outcome. A digital medicine system (DMS) has been developed to address this need in patients with serious mental illness.
Objective:
To conduct a quantitative expert consensus survey to (1) assess relative importance of causes of suboptimal outcomes, (2) examine modalities used to assess adherence, (3) provide guidance on when and how to use the DMS in clinical practice once available, and (4) suggest interventions for specific reasons for nonadherence.
Methods:
A panel of 58 experts in psychiatry completed a 23-question survey (October 13 through December 23, 2013) and rated their responses on a 9-point Likert scale. A χ² test of score distributions was used to determine consensus (P < .05).
Results:
The panel rated adherence as the most important factor in suboptimal outcomes and yet the least likely to be assessed accurately. All predefined uses of the DMS received high mean first-line ratings (≥ 7.4). The experts recognized the utility of the DMS in managing adherence problems, identified clinical situations appropriate for DMS, and assessed potential benefits and challenges of this technology. Consensus was reached on first-line interventions for 10 of 11 reasons for nonadherence.
Conclusions:
The results provide a guide to clinicians on the evaluation of suboptimal outcomes, when and how to use the DMS, and the most appropriate interventions to address detected adherence problems.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Drug Dosing: Geriatric Patients
Psychosis: Goals of Pharmacotherapy
Dosage Regimens: Designs and Approaches
Oral Drug Delivery Systems: Continuous-Release Systems
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

